ArrHub

Know who’s entering your market™Sachez qui entre sur votre marchéMC

FRPremium subscriptionSubscribe

FDA PMA supplement record

P220032/S006

POLARx/POLARx FIT Cryoablation Catheters, SMARTFREEZE Cryoablation Console, Accessories

Supplement S006 to premarket approval P220032. Product code OAE. Decision 5 July 2024.

Approval

Each row is one field of the openFDA record. The grey name is the field’s name in openFDA’s documentation.

FieldValueField name
PMA numberP220032pma_number
Supplement numberS006supplement_number
ApplicantBoston Scientific Corporationapplicant
Trade namePOLARx/POLARx FIT Cryoablation Catheters, SMARTFREEZE Cryoablation Console, Accessoriestrade_name
Generic nameCatheter, percutaneous, cardiac ablation, for treatment of atrial fibrillationgeneric_name
Product codeOAEproduct_code
Advisory committeeCardiovascularadvisory_committee_description
Date received2024-06-05date_received
Decision date2024-07-05decision_date
Decision codeAPPRdecision_code
Supplement typeNormal 180 Day Track No User Feesupplement_type
Supplement reasonPostapproval Study Protocolsupplement_reason

Source: FDA openFDA, device/pma, P220032/S006, retrieved 2026-10-16 02:28 Eastern. Public domain (CC0).

Product code

The FDA classification record for the code on this record.

OAE

Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation

Device class 3 · Review panel CV

ArrHub vocabulary

Electrophysiology

OAE is one of the 61 product codes in ArrHub’s electrophysiology vocabulary, each held with its FDA classification record as its citation. Vocabulary entry verified 20 September 2026.

Supplement history

Every record of this PMA number in ArrHub’s verified view, newest first. Routine notices are listed, never summarised away.

RecordTypeReasonDecision
P220032 FDAoriginal approvalempty2023-08-08
P220032/S012 FDANormal 180 Day Track No User FeePostapproval Study Protocol2026-05-29
P220032/S011 FDANormal 180 Day Track No User FeeLocation Change - Manufacturer/Sterilizer/Packager/Supplier2025-08-14
P220032/S010 FDASpecial (Immediate Track)Labeling Change - Indications/instructions/shelf life/tradename2025-03-21
P220032/S009 FDA30-Day NoticeProcess Change - Manufacturer/Sterilizer/Packager/Supplier2025-02-10
P220032/S004 FDANormal 180 Day Track No User FeeLocation Change - Manufacturer/Sterilizer/Packager/Supplier2024-10-18
P220032/S008 FDA30-Day NoticeProcess Change - Manufacturer/Sterilizer/Packager/Supplier2024-09-12
P220032/S007 FDA30-Day NoticeProcess Change - Manufacturer/Sterilizer/Packager/Supplier2024-08-23
P220032/S005 FDAReal-Time ProcessChange Design/Components/Specifications/Material2024-07-30
P220032/S006 FDANormal 180 Day Track No User FeePostapproval Study Protocol2024-07-05
P220032/S003 FDA30-Day NoticeProcess Change - Manufacturer/Sterilizer/Packager/Supplier2024-03-18
P220032/S002 FDA30-Day NoticeProcess Change - Manufacturer/Sterilizer/Packager/Supplier2023-12-12
P220032/S001 FDANormal 180 Day Track No User FeePostapproval Study Protocol2023-11-17

Source: FDA openFDA, device/pma, records of P220032, retrieved 2026-10-16 02:28 Eastern. 13 records in the verified view. Each identifier links to the FDA’s page.

ArrHub

What ArrHub adds to the record. Everything above this line is the agency’s; everything here is ArrHub’s, dated and attributed.

Record pair

No confirmed pair across the two registers for this record.

Resolution

No verified alias in ArrHub’s table; the name stands as the register spells it.

Not yet in ArrHub’s weekly snapshot.

Raw record

The stored record exactly as ArrHub holds it, for anyone who wants to check the page against it.

Show the raw record (JSON)device/pma.json?search=pma_number:P220032+AND+supplement_number:S006&limit=1
{
  "id": "ddfdf2f4-349b-4b09-8b74-e6924ce6e8e6",
  "pma_key": "P220032/S006",
  "pma_number": "P220032",
  "supplement_number": "S006",
  "applicant": "Boston Scientific Corporation",
  "trade_name": "POLARx/POLARx FIT Cryoablation Catheters, SMARTFREEZE Cryoablation Console, Accessories",
  "generic_name": "Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation",
  "product_code": "OAE",
  "advisory_committee_description": "Cardiovascular",
  "decision_date": "2024-07-05",
  "decision_code": "APPR",
  "supplement_type": "Normal 180 Day Track No User Fee",
  "supplement_reason": "Postapproval Study Protocol",
  "date_received": "2024-06-05",
  "source_url": "https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P220032&s=S006",
  "verified_at": "2026-10-16T06:52:57.529+00:00",
  "created_at": "2026-10-16T06:28:37.266536+00:00",
  "collected_at": "2026-10-16T06:28:22.358+00:00",
  "last_checked_at": "2026-10-16T06:52:57.529+00:00"
}

The readable page is rendered from the record held in ArrHub’s verified view; the agency record at api.fda.gov governs where they differ.

Links open the agency’s own records. Unlabelled links open web pages. Links marked (JSON) open an agency’s data record, which a browser shows as plain text.

Report a broken link or a record that does not match its source: alerts@arrhub.com. Corrections are published, with their date, at arrhub.com/corrections.

© 2026 ArrHub. Content made available under licence.